Hurricane Capital Advisors’s Standard BioTools LAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
– Sell
-11,505
Closed -$20.4K – 601
2024
Q2
$20.4K Sell
11,505
-20,900
-64% -$51.1K 0.01% 441
2024
Q1
$87.8K Buy
+32,405
New +$78.2K 0.02% 366

Other funds holding LAB

Hurricane Capital Advisors's LAB Position: Q3 2024 in Review

Hurricane Capital Advisors sold out of Standard BioTools (LAB) in Q3 2024, closing a stake of 11,505 shares — an estimated $20.4K sold.

Hurricane Capital Advisors first reported a position in LAB in Q1 2024 and held it in 2 quarters. The position peaked at $87.8K in Q1 2024. 141 funds tracked by Wall St. Rank hold LAB as of Q3 2024.

  • Hurricane Capital Advisors reported no remaining Standard BioTools position as of Q3 2024 after selling out during the quarter.
  • Hurricane Capital Advisors sold 11,505 Standard BioTools shares in Q3 2024, an estimated $20.4K.
  • Hurricane Capital Advisors first reported a position in Standard BioTools in Q1 2024 and held it in 2 quarters.
  • Hurricane Capital Advisors's Standard BioTools position peaked at $87.8K in Q1 2024.
  • 141 funds tracked by Wall St. Rank held Standard BioTools as of Q3 2024.

Based on Hurricane Capital Advisors's 13F filing for Q3 2024, filed 3 Nov 2026.